Skip to main content
. Author manuscript; available in PMC: 2008 Apr 1.
Published in final edited form as: J Neuroimmunol. 2007 Feb 27;185(1-2):168–174. doi: 10.1016/j.jneuroim.2007.01.011

Table 2(B).

Changes in Serum and Cellular Cytokine levels over 24 weeks of IFN-beta tiw (n=7)

pg/ml mean±SE Pre-Rx mean 4 weeks 8 weeks 12 weeks 16 weeks 20 weeks 24 weeks Post-Rx mean
Serum IL10 15.14±1.08 14.40±0.84 13.55±1.45 15.73±1.56 14.72±1.39 13.91±1.16 14.19±1.61 14.42±0.53
Serum IL12p70 76.15±9.05 80.75±15.48 88.92±15.60 75.71±10.41 70.62±13.11 64.17±13.78 73.31±13.62 75.58±5.41*
Serum 10/12p70 0.208 ± 0.027 0.217 ± 0.038 0.178 ± 0.030 0.220 ± 0.021 0.260 ± 0.047 0.276 ± 0.063 0.235 ± 0.050 0.231±0.017
cellular IL10 360.7±121.8 427.6±220.1 412.8±155.0 725.5±149.7 1499±600.2 1246±594.4 1648±992.3 993.1±223.0
cellular IL12p40 2146±548.1 1602±282.6 1168±308.1 2125±508.1 1753±345.9 1635±317.8 1033±136.5 1578±141.3
cellular IL12p70 75.21±20.85 84.84±26.67 106.9±40.22 247.3±76.49 214.7±89.97 102.5±29.26 81.64±23.72 139.7±23.18
cellular IFN-g 755.7±222.3 451.9±131.4 244.8±111.7 482.2±214.0 341.8±127.7 434.3±187.7 341.9±139.6 382.8±61.12

†=value significantly different vs. pre-treatment (p<0.05 by repeated measures ANOVA)

*=value significantly different vs qw (p<0.05 by Mann-Whitney)